This document discusses structure-activity relationships in drug design and formulation. It introduces Hammett and Hansch plots, which relate reaction rates and biological activity to electronic and physicochemical properties. Modification of lead compounds is explored through changing functional groups, stereochemistry and lipophilicity. Morphine is used as a case study to illustrate how properties like log P, binding groups and stereochemistry impact opioid activity. The conclusion emphasizes the role of medicinal chemistry in understanding disease and developing safer, more effective pharmaceuticals.